Jaguar Health, Inc. Modification Agreements

22 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to At The Market Offering Agreement among Jaguar Health, Ladenburg Thalmann & Co., and Lucid Capital Markets (February 2025)
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2025
Amendment to Secured Promissory Note between Streeterville Capital, LLC, Jaguar Health, Inc., and Napo Pharmaceuticals, Inc.
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2025
Amendment to At The Market Offering Agreement among Jaguar Health, Ladenburg Thalmann & Co., and Lucid Capital Markets (November 2024)
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2024
Global Amendment No. 2 to Royalty Interest Agreement between Jaguar Health, Inc. and Streeterville Capital, LLC
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Global Amendment No. 1 to Royalty Interest Agreement between Jaguar Health, Inc. and Streeterville Capital, LLC
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Global Amendment No. 2 to Royalty Interest Agreement between Jaguar Health, Inc. and Uptown Capital, LLC
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Global Amendment No. 2 to Royalty Interest Agreement between Jaguar Health, Inc. and Iliad Research and Trading, L.P.
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Memorandum of Understanding Modifying Warrant Allocation under Standstill Agreement among Jaguar Health, Napo Pharmaceuticals, Iliad Research, Uptown Capital, and Streeterville...
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
First Amendment to Standstill Agreement among Jaguar Health, Napo Pharmaceuticals, and Investors
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Global Amendment to Secured Promissory Note and Note Purchase Agreement by and among Streeterville Capital, LLC, Jaguar Health, Inc., and Napo Pharmaceuticals, Inc.
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2022
Global Amendment to Secured Promissory Note between Streeterville Capital, LLC, Jaguar Health, Inc., and Napo Pharmaceuticals, Inc.
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2022
Global Amendment to Royalty Interest Agreement between Streeterville Capital, LLC and Jaguar Health, Inc.
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2022
Global Amendment to Royalty Interest Agreement between Uptown Capital, LLC and Jaguar Health, Inc. (April 14, 2022)
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2022
Global Amendment to Royalty Interest Agreement between Iliad Research and Trading, L.P. and Jaguar Health, Inc. (April 14, 2022)
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2022
Global Amendment to Secured Promissory Note among Chicago Venture Partners, Napo Pharmaceuticals, and Jaguar Health
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
First Amendment to Royalty Interest Purchase Agreement between Jaguar Health, Inc. and Iliad Research and Trading, L.P.
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
First Amendment to Landlord Letter of Credit & Warrant Issuance Agreement between Jaguar Health, Inc. and Pacific Capital Management, LLC
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Amendment to Securities Purchase Agreement between Jaguar Health, Inc. and Chicago Venture Partners, L.P. (August 30, 2017)
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2017
Amendment to Debt Settlement Agreement between Napo Pharmaceuticals, Inc. and Boies Schiller Flexner LLP (September 1, 2017)
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2017
Amendment to Debt and Warrant Settlement Agreement between Napo Pharmaceuticals, Inc. and Feinberg Parties (Dorsar Investment Company, Alco Investment Company, Two Daughters LLC)
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2017
Amendment to Note Purchase Agreement between Napo Pharmaceuticals, MEF I, LP, and Riverside Merchant Partners (September 1, 2017)
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2017
Amendment No. 1 to Employee Leasing and Overhead Allocation Agreement between Jaguar Animal Health, Inc. and Napo Pharma
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2017